Mesenchymal stromal cells in bone marrow express adiponectin and are efficiently targeted by an adiponectin promoter-driven Cre transgene

Stromal cells in bone marrow (BM) constitute a specific microenvironment supporting the development and maintenance of hematopoietic cells. Adiponectin is a cytokine secreted by adipocytes. Besides its anti-diabetic and anti-atherogenic roles, adiponectin reportedly regulates the development and function of hematopoietic cells in BM. However, it remains unclear whether mesenchymal stromal cells in BM express adiponectin. Here, we show that PDGFRβ+VCAM-1+ stromal cells express adiponectin. Lineage tracing revealed that a majority of PDGFRβ+VCAM-1+ cells were targeted by an adiponectin promoter-driven Cre (Adipoq-Cre) transgene. Additionally, the Adipoq-Cre transgene targets a minority of osteoblasts at a younger age but larger populations are targeted at an older age. Furthermore, the Adipoq-Cre transgene targets almost all CXCL12-abundant reticular (CAR) cells and most of the stromal cells targeted by the Adipoq-Cre transgene are CAR cells. Finally, deletion of interleukin-7 (IL-7) by the Adipoq-Cre transgene resulted in severe impairment of B lymphopoiesis in BM. These results demonstrate that PDGFRβ+VCAM-1+ stromal cells in BM express adiponectin and are targeted by the Adipoq-Cre transgene, suggesting a broader specificity of the Adipoq-Cre transgene

Expression of myogenin, MyoD and MHC isoforms in regenerating skeletal muscle.

骨格筋再生過程におけるミオシン重鎖(MHC)アイソフォーム発現とmyogenin，MyoDタンパクの発現様式との関連性を検討するために，塩酸ブピバカインを用いてマウスヒラメ筋損傷モデルを作成し，損傷筋の再生過程を組織形態学的に確認すると同時に，再生各段階におけるMHCアイソフォームと，myogeninおよびMyoDタンパク発現を経時的に検索した．本研究における筋損傷は塩酸ブピバカインをマウス(C57BL/10SnSlc)のヒラメ筋に注入することで作成した．組織学的には，塩酸ブピバカイン投与後3日目で筋線維はほとんど消失し，処置後6日目で中心核を有する再生筋線維がかなり出現し，処置後28日目では対照群のものと同程度まで回復した．生化学的分析では，対照群ヒラメ筋はMHCⅠ(34．3±1．7%)とMHCⅡa(65．7±1．7%)で構成されていた．実験群ヒラメ筋ではMHCⅠは処置後14日目まで減少し，その後増加傾向を示し，処置後90日目では36．3±2．9%となった．また，正常ヒラメ筋では検出されない速筋型MHC(MHC Ⅱd，MHC Ⅱb)が処置後3日目から28日目まで検出された．Western blotを用いた分析では，myogeninタンパク正常ヒラメ筋（遅筋）で検出された一方，前脛骨筋（速筋）においては検出できなかった．実験群ヒラメ筋では，myogeninは対照群と比較して処置後３日目より増加し（3．1±0．5），処置後６日目でピークに達した（5．8±0．8）．それからmyogeninタンパクは徐々に減少していったが，処置後90日目においてもなお対照群ヒラメ筋の1．8倍の発現を維持し続けた．一方，MyoDタンパクは正常前脛骨筋において正常ヒラメ筋の3．3倍の発現が認められた．MyoDは処置後３日目で対照群ヒラメ筋と比較して5．4倍になりピークに達した．その後は徐々に減少し始めた．しかし処置後90日目においても2．2倍の発現があった．これらのことから筋の再生過程においては速筋タイプの筋細胞が出現するmyogeninとMyoDは衛星細胞の分化と筋の再生に密接に関係していることが示唆された．To investigate the precise mechanism of skeletal muscle cell regeneration, the changing pattern ofmyosin heavy chain(MHC)isoforms during the regenerating process was observed with relation to theactivation of myogenin and MyoD. In addition, histopathological observation of the damaged muscles wasperformed throughout the experiment.In this study, muscle damage was induced by intramuscular injection of bupivacaine hydrochloride in thesoleus muscle of mice (C57BL/10SnSc). In the light microscopic observation, muscle cells had almost disappeared at 3 days after bupivacainetreatment with severe inflammatory cell infiltration. At 6 days after treatment, a considerable number ofregenerating muscle cells containing centrally located nuclei appeared in the damaged soleus muscle. At28 days, these regenerating muscle cells showed almost the same appearance as the control muscle cellscontaining subsarcolemmal nuclei, although a small number of muscle cells with central nuclei were stillrecognized.In the biochemical analysis, control soleus muscles contained only MHC I (34.3±1.7 %)and MHC IIa(65.7±1.7 %). In the damaged muscles, MHC I was decreased toward 14 days after treatment, and thengradually increased. At 90 days, the contents of MHC I was finally recovered to 36.3±2.9 %.0 In addition,MHC IId and MHC IIb appeared in the damaged muscle from 3 to 28 days after treatment. However, theyhad disappeared at 90 days.Using western blot analysis, myogenin protein was recognized in the control soleus muscles (slow typemuscle), while the myogenin could not be found in the first type muscle of the anterior tibial muscle. Themyogenin contents increased to about three fold (3.1±0.5)at 3 days after treatment compared withthose of control muscles and reached the maximum level (5.8±0.8)at 6 days after treatment. Then, myogenin contents gradually decreased,although they still remained high (1.8 times)at the end of experiment (90 days after treatment). Incontrast to the myogenin protein, a high level (3.3 times)of MyoD protein was detected in the anteriortibial muscle compared with that of control soleus muscles. In the damaged soleus muscles, MyoDcontents reached a maximum level (5.4 times)at 3 days after treatment compared with that of controlsoleus muscles, and then gradually decreased toward the end of experiment. However, MyoD protein stillremained 2.2 times compared with that of control soleus muscles. These findings described above indicate that, 1)a property of fast type muscle cells appeared in theregenerating muscle cells during the regenerating process, and 2)myogenin and MyoD are closelyrelated to the differentiation of the satellite cells and regeneration of the skeletal muscle cells

Genetic population structure of the polkadot skate (Dipturus chinensis) around Japan, based on mitochondrial DNA sequences and polymorphic microsatellite loci

The genetic population structure of the polkadot skate (Dipturus chinensis) around Japan was examined by using mitochondrial (mt) cytochrome (cyt) b gene sequences and polymorphic microsatellite (simple sequence repeat [SSR]) loci. Results of phylogenetic analysis based on mt cyt b gene sequences reveal 2 major lineages, clades A and B. Clade A consists of populations in the Sea of Japan and the East China Sea. Clade B contains populations in the Pacific Ocean and is divided into 2 subclades, clades B1 and B2, which correspond to the populations along the southern and northern coasts of Japan, respectively. This genetic differentiation is also supported by results from SSR analysis. The divergence of clades A and B may reflect isolation of the East China Sea from the Pacific Ocean in the Early Pleistocene. After diverging from clade A, clade B might have extended its distribution northward along the Pacific coast of Japan and divided into clades B1 and B2 in the Middle Pleistocene. The polkadot skate is clearly structured into 3 genetically discrete populations around Japan that should be treated as independent management units for management of this species in the future

The role of astrocytes during repair of cerebral infarction in mdx mice

様々な大きさのジストロフィンアイソフォーム(427kDa, 260kDa, 140kDa, 116kDa, 71-75kDa)が広く体内に存在していることはよく知られている.中枢神経系においては71-75kDaのDp71が著明に多く,毛細血管の内皮の基底膜に接しているアストロサイトの細胞質に局在することが報告されている.しかしながらDp71の機能についてはよくわかっていないことが多い.そこで今回,脳組織におけるDp71の役割を調べるために,コントロールマウス(wild-typeマウス)およびデュシャンヌ型筋ジストロフィーモデル動物であるmdxマウスを用いて実験的脳梗塞を作成し,その治癒過程を形態学的に観察した.また,GFAPおよびDp71に関して生化学的に分析をおこなった.HE染色およびGFAP免疫組織学的染色の結果から,形態学的にはmdxマウスとコントロールマウスの脳に違いは認められなかった.しかしながら,mdxマウスの脳において,Dp71の発現量がコントロールマウスよりも少ないことがわかった.またmdxマウスにおいて,脳梗塞の修復過程におけるアストロサイトの反応がコントロールマウスよりも弱いことがわかった.これらの結果から,mdxマウスの脳において,アストロサイトの機能,アストロサイトの血管新生に関わる機能の障害されていることが示唆された.It is now well known that dystrophin isoforms (427kDa, 260kDa, 140kDa, 116kDa, 71-75kDa) are widely distributed throughout our body. In the central nervous system a considerable amount of Dp71 (71-75kDa) is found in the perivascular cytoplasm of the astrocytes. However, the function of this dystrophin is still unknown. To investigate the role of Dp71 in the brain tissue, cerebral infarction was induced in the control (wide-type) mouse and mdx mouse which is known as an animal model of human muscle dystrophy (Duchenne type), and morphological changes of the infarcted area were observed during repair of the infarction. In addition, biochemical analysis of GFAP and Dp71 was carried out in the brain of the control and mdx mouse. In our present study, there were no differences in brain morphology between mdx and control mouse as revealed in H-E stain and GFAP immunohistochemistry. However, the Dp71 were smaller in quantity in the brain of the mdx mouse than that of the control mouse. The reaction of astrocytes during repair of serebral infarction was distinctly delayed in the mdx mouse compared with that of the control mouse. These findings suggest that the astrocytes in the brain of the mdx mouse are functionally impaired including perivascular cytoplasmic processes with relation to neo-vascularization

コウウンドウセイ モデル ラット SPORTS ノ カイバ ニオケル ノルエピネフリン ドウタイ ト ジハツ ウンドウリョウ

Reduced physical exercise activity contributes to the development of several metabolic disorders including obesity, type ２ diabetes and hypertension. Especially in the developed countries, many people choose not to be active physically, possibly because of a reduced motivation to participate in exercise activities. Thus, augmentation of exercise motivation and subsequent increase in the physical activity would reduce an incidence of these metabolic disorders. In order to clarify the psychological mechanisms responsible for an increased exercise activity, we have generated and established a line of SPORTS （Spontaneously-Running-Tokushima-Shikoku） rat for high levels of voluntary wheel running. Male SPORTS rats run voluntarily in the running wheel almost six times longer than control Wistar rats. Here we examined the relation of the running activity of SPORTS rat with the hippocampal norepinephrine （NE） system including the levels of NE, adrenergic receptors, and degradation enzymes for monoamines. In the hippocampus of SPORTS rats, the level of NE in extracellular fluid was augmented, whereas the level in the homogenate of the whole tissue was decreased even for sedentary conditions. The level of striatal dopamine has not altered in both groups. The protein expression and the activity levels of monoamine oxidase A （MAOA）, a critical enzyme for the degaradation of NE, were decreased in the hippocampus of SPORTS rats to increase extracellular NE level. Thus, inhibition of oxidase activity in normal Wistar rats markedly increased wheel running activity. Our results indicate that the hippocampal NE determines the neural basis of the psychological regulation of exercise behavior in SPORTS rats. Modulation of NE transmission in the hippocampus will be a good method for enhancing the exercise behavior both in clinical patients and in healthy humans

Function of skeletal muscle sarcoplasmic reticulum and expression of sarcoplasmic reticulum Ca2+-ATPase in right congestive heart failure rats

右心不全に伴って,速筋および遅筋の筋小胞体Ca2+取り込み能が減少するという仮説を検証した.右心不全は,モノクロタリン(30 ㎎/㎏)を投与することにより引き起こし,投与後4週で,長指伸筋およびヒラメ筋を両後肢から採取した.筋の疲労耐性は,連続的な強縮刺激を行うことにより測定した.長指伸筋では刺激開始1分後,ヒラメ筋では4分後の張力を測定し,初期値に対するそれらの割合を疲労の指標とした.長指伸筋およびヒラメ筋の疲労耐性は,右心不全群で有意に低下した.筋小胞体Ca2+取り込み速度は,Indo-Ⅰを付加したホモジネートで測定した.その結果,Ca2+取り込み速度は,長指伸筋で25.4%(p<0.01),ヒラメ筋で30.4%(p<0.05)低下した.このCa2+取り込み速度の低下は,筋小胞体Ca2+-ATPaseタンパク量の低下と一致した.筋小胞体Ca2+取り込み能の低下は,筋張力の低下を引き起こし,このCa2+ handlingの低下は,少なくとも右心不全による運動耐容能の低下の一因であろう.In this study, we investigated the hypothesis that right congestive heart failure (CHF) would impair sarcoplasmic reticulum (SR) Ca2+ uptake in skeletal fast- and slow-twitch muscles. To induce CHF, the rats were injected with monocrotalin (30 ㎎/㎏). After 4 weeks of injection, extensor digitorum longus (EDL) and soleus (SOL) muscles were sampled from both hind limbs. Muscle fatigue resistance was measured in vitro as the relative decline in force production of tetanic contraction induced by electrical stimulation over 1 and 4 min in EDL and SOL, respectively. Evaluation of fatigue characteristics showed that CHF significantly reduced fatigue resistance in both muscles under study.SR Ca2+uptake rate wasmeasured in vitro with Indo-I on muscle homogenates. As hypothesized, Ca2+uptake rate was decreasedby 25.4%(P < 0.01) and 30.4%(P < 0.05) in EDL and SOL, respectively. This decline in Ca22+uptake ratewas accompanied by an immunochemically determined decrease in SR Ca2+-ATPase protein. Taking intoaccount previous findings that the depressed SR Ca2+uptake leads to the reduce in muscle forceproduction, these results suggest that impaired SR Ca2+handling capacity in skeletal muscle may accountat least partly for deteriorations in exercise tolerance resulting from right CHF

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis

Background: Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. Within the spectrum of NAFLD, non-alcoholic steatohepatitis (NASH) in combination with hepatic inflammation and fibrosis can lead to liver cirrhosis and hepatocellular carcinoma. Dysbiosis was reported to contribute to NASH pathogenesis. This study aimed to determine the effects of fructo-oligosaccharides (FOS) on steatohepatitis and visceral adiposity in an obese mouse model of NASH. Methods: Twelve newborn C57BL/6 J male mice were subcutaneously injected with monosodium glutamate (MSG) to induce obesity on a conventional diet. Six mice were also administered 5% FOS via drinking water from 10 weeks of age. At 18 weeks, histological characteristics of the liver and epididymal fat were compared between the groups. Hepatic mRNA expression of lipid metabolism enzymes and SCFA in feces and sera were measured. Results: Hepatic steatosis, inflammatory cell infiltration, and hepatocyte ballooning in the liver and increased hepatic mRNA expression of fatty acid synthase and glycerol-3-phosphate acyltransferase were observed in the MSG-treated mice. FOS treatment improved the liver pathology and blunted the increases in the mRNA expression levels of lipid metabolism enzymes. In addition, FOS inhibited adipocyte enlargement and formation of crown-like structures and reduced the M1 macrophage frequency in the epididymal fat of the MSG mice (39.4% ± 3.0% vs. 22.8% ± 0.7%; P = 0.001). FOS increased not only the fecal concentrations of n-butyric acid (0.04 ± 0.01 vs. 0.38 ± 0.14 mg/g, P = 0.02), propionic acid (0.09 ± 0.03 vs. 0.42 ± 0.16 mg/g, P = 0.02), and acetic acid (0.65 ± 0.16 vs. 1.48 ± 0.29 mg/g, P = 0.03) but also the serum concentration of propionic acid (3.9 ± 0.5 vs. 8.2 ± 0.5 μmol/L, P = 0.001). Conclusions: FOS ameliorates steatohepatitis, visceral adiposity, and chronic inflammation by increasing SCFA production

Intestinal epithelial cell-derived IL-15 determines local maintenance and maturation of intraepithelial lymphocytes in the intestine

Interleukin-15 (IL-15) is a cytokine critical for maintenance of intestinal intraepithelial lymphocytes (IELs), especially CD8αα+ IELs (CD8αα IELs). In the intestine, IL-15 is produced by intestinal epithelial cells (IECs), blood vascular endothelial cells (BECs) and hematopoietic cells. However, the precise role of intestinal IL-15 on IELs is still unknown. To address the question, we generated two kinds of IL-15 conditional knockout (IL-15cKO) mice: villin-Cre (Vil-Cre) and Tie2-Cre IL-15cKO mice. IEC-derived IL-15 was specifically deleted in Vil-Cre IL-15cKO mice, whereas IL-15 produced by BECs and hematopoietic cells is deleted in Tie2-Cre IL-15cKO mice. The cell number and frequency of CD8αα IELs and NK IELs were significantly reduced in Vil-Cre IL-15cKO mice. By contrast, CD8αα IELs were unchanged in Tie2-Cre IL-15cKO mice, indicating that IL-15 produced by BECs and hematopoietic cells is dispensable for CD8αα IELs. Expression of an anti-apoptotic factor, Bcl-2, was decreased, whereas Fas expression was increased in CD8αα IELs of Vil-Cre IL-15cKO mice. Forced expression of Bcl-2 by a Bcl-2 transgene partially restored CD8αα IELs in Vil-Cre IL-15cKO mice, suggesting that some IL-15 signal other than Bcl-2 is required for maintenance of CD8αα IELs. Furthermore, granzyme B production was reduced, whereas PD-1 expression was increased in CD8αα IELs of Vil-Cre IL-15cKO mice. These results collectively suggested that IEC-derived IL-15 is essential for homeostasis of IELs by promoting their survival and functional maturation

Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells.

alpha-Defensins, antimicrobial peptides produced mainly by neutrophils, have been reported to be associated with a wide variety of lung diseases, including idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), and diffuse panbronchiolitis (DPB). In each disease, alpha-defensins are located in different areas, such as around the alveolar septa in IPF and around the airways in CF and DPB, suggesting that alpha-defensins play different roles. Meanwhile, growth factors are known to contribute to IPF, CF, and DPB. alpha-Defensins are known to induce interleukin (IL)-8 in airway epithelial cells, but the effects of alpha-defensins on the release of growth factors from various components in the lung have not been sufficiently investigated. In the present study, the in vitro effects of human neutrophil peptide (HNP)-1 (a subtype of alpha-defensin) on the expressions of IL-8 and growth factors in lung fibroblasts, bronchial epithelial cells, and alveolar epithelial cells were examined. HNP-1 mainly enhanced the expression of IL-8 in epithelial cells, whereas it enhanced transforming growth factor-beta and vascular endothelial growth factor expressions in lung fibroblasts. These results suggest that alpha-defensins play different roles in the pathogenesis of IPF, CF, and DPB according to the location in the lung where the alpha-defensins are mainly produced